Vaccine education survey: Have your say!
Now that we are back, we want your input, insights feedback to ensure the educational content we provide meets your needs.
Please support our relaunch by completing this brief survey (3–5 minutes).
Coming soon: Immunisation Skills Workshop – Friday 28 March 2025
MVEC will be holding a half-day workshop focused in the areas of:
- promoting vaccine confidence
- how to have difficult conversations.
日期： Friday 28 March 2025
时间： 8:00 am – 1:30 pm AEDT
地点： Murdoch Children's Research Institute
Registrations will be opening soon
Learn more: MVEC: Immunisation Skills Workshop – Friday 28 March 2025.
Register now: CVU mini – Wednesday 5 February 2025 (webinar)
MVEC’s upcoming CVU mini will be on the topic of RSV preventative therapies.
This webinar offers healthcare professionals the opportunity to hear from leading experts on the latest in RSV prevention.
Hear from Prof Nigel Crawford, Dr Ingrid Laemmle-Ruff and Ms Rachael McGuire, followed by a brief Q&A session.
日期： Wednesday 5 February 2025
时间： 6:00–7:00 pm AEDT
地点： online (zoom link will be provided)
注册费用： free event
Learn more and register: MVEC: CVU mini – Wednesday 5 February 2025.
For more information about RSV, go to MVEC：呼吸道合胞病毒（RSV）.
National Immunisation Program: New meningococcal vaccine funded from 1 July 2024
From 1 July 2024, the meningococcal ACWY vaccine MenQuadfi will be funded on the National Immunisation Program (NIP).
Invasive meningococcal disease (IMD) is caused by infection with the bacteria Neisseria meningitidis. It can result meningitis and septicaemia, as well as other infections like pneumonia, arthritis and conjunctivitis. Children under 2 years have the highest incidence of meningococcal disease in Australia, with another peak among adolescents and young adults aged 15 to 24 years.
MenQuadfi replaces Nimenrix for the adolescent age group (year 10 equivalent and up to 19 years for catch up). Children aged 12 months and those with specific medical conditions will continue to receive the Nimenrix vaccination on the NIP.
MenQuadfi was registered for use by the Therapeutic Goods Administration (TGA) in 2020. It is given as a single 0.5 mL dose, to be administered intramuscularly.
NIP: Meningococcal ACWY vaccines – updates for 1 July 2024
TGA: MenQuadfi
MVEC：脑膜炎球菌
Victorian Department of Health: Changes to mpox vaccine eligibility criteria
Mpox is a viral zoonosis (an infection spread from animals to humans). Since April this year, there have been 24 confirmed cases of mpox in Victoria, 21 of which were locally acquired.
In Victoria, the eligibility criteria for free primary prevention vaccination (PPV) and post-exposure preventative vaccinations (PEPV) have been expanded.
Find out more about the recent transmission and accessing vaccines at Victorian Department of Health: Changes to mpox vaccine eligibility criteria.
OPTIONS XII for the Control of Influenza: Early bird registration extended
OPTIONS for the Control of Influenza is a global scientific meeting with a dedicated focus on influenza. OPTIONS XII will be held in Brisbane from Sunday 29 September to Wednesday 2 October 2024.
Highlights of this year’s conference include focuses on:
- Pacific Island and First Nations health
- interdisciplinary science
- knowledge exchange and networking
- policy and advocacy.
Submissions for late breaking orals and posters are open until 11 July 2024.
Early bird registrations have been extended to 30 June 2024.
Learn more about OPTIONS XII and abstract submission on the OPTIONS XII website.
Updated immunisation reference: Australian Immunisation Register (AIR)
MVEC has recently updated its reference page on the Australian Immunisation Register (AIR).
The updated page includes information about new fields added in 2024, and general guidance on how to use AIR, and what it should be used for.
MVEC: Australian Immunisation Register (AIR)
ProQuad stock due to expire 16 June
Stock of the measles-mumps-rubella-varicella (MMRV) vaccine ProQuad is due to expire on 16 June 2024.
ProQuad will cease to be listed on the National Immunisation Program (NIP) schedule on 1 July 2024.
Vaccines must be disposed of immediately when the expiry date is reached, according to your state or territory's requirements.
Department of Health and Aged Care: 2024 flu season and respiratory illnesses webinar recording available
A recording of the Australian Government Health Department’s 3 May webinar on the 2024 flu season and respiratory illnesses is now available to view.
The webinar was presented by Professor Paul Kelly (Head of the interim Australian Centre for Disease Control) and Professor Nigel Crawford.
The webinar is for vaccine providers, including:
- general practitioners
- 药房自行购买疫苗。
- primary care nurses
- allied health professionals.
Department of Health and Aged Care: 2024 flu season and respiratory illnesses webinar
Immunisation Coalition: RSV update webinar
这 Immunisation Coalition will hold its RSV update webinar on 26 June, from 6:00 pm (AEST).
The webinar will be moderated by Dr Andrew Minton and features Dr Gemma Saravanos as speaker.
Learn more and register on the Immunisation Coalition’s event page.